Daniel Geffken
Finanzdirektor/CFO bei ELOXX PHARMACEUTICALS, INC.
Vermögen: 26 536 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Daniel Geffken
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Harvard Business School
246
| College/University | Other Consumer Services | 246 |
The Wharton School of the University of Pennsylvania
195
| College/University | Other Consumer Services | 195 |
Danforth Advisors LLC
 Danforth Advisors LLC Investment ManagersFinance Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA.
26
| Holding Company | Investment Managers | 26 |
| Public Company | Pharmaceuticals: Other | 24 | |
| Public Company | Biotechnology | 22 | |
| Public Company | Biotechnology | 21 | |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA.
14
| Extinct | Miscellaneous Commercial Services | 14 |
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel.
13
| Extinct | Pharmaceuticals: Major | 13 |
| Unknown | 13 | ||
Promedior, Inc.
 Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA.
11
| Subsidiary | Medical Specialties | 11 |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
10
| Extinct | Pharmaceuticals: Major | 10 |
| Holding Company | Biotechnology | 9 | |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA.
9
| Subsidiary | Biotechnology | 9 |
Palvella Therapeutics, Inc.
 Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA.
9
| Holding Company | Biotechnology | 9 |
| Public Company | Pharmaceuticals: Major | 8 | |
DermBiont, Inc.
 DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA.
8
| Holding Company | Miscellaneous Commercial Services | 8 |
Lysosomal Therapeutics, Inc.
 Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lysosomal Therapeutics, Inc. engages in the innovation, research, and development in the field of neurodegeneration. It focuses in lysosomal biology in developing novel small molecules for use in the treatment of neurodegenerative diseases. The company was founded by Dimitri Krainc, Joseph Mazzulli, Henri A. Termeer, Robert J. Carpenter, Peter Wirth, Edmund J. Sybertz, and Kees Cornelis Been in 2011 and is headquartered in Cambridge, MA.
8
| Extinct | Pharmaceuticals: Major | 8 |
GenePeeks, Inc.
 GenePeeks, Inc. Packaged SoftwareTechnology Services GenePeeks, Inc. develops software that provides genetic information to reduce the risk of heritable diseases. It simulates the genetic reduction and recombination by digitally weaving together the DNA of prospective parents. The company was founded by Anne Morriss and Lee Silver in 2009 and is headquartered in Albany, NY.
8
| Holding Company | Packaged Software | 8 |
Vigeo Therapeutics, Inc.
 Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vigeo Therapeutics, Inc. manufactures cancer drugs. It develops therapies designed to reprogram the tumor immune microenvironment by targeting CD36 and CD47 via Tsp-1 induction. The company was founded by Randolph Watnick and Jing Watnick in 2011 and is headquartered in Cambridge, MA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA.
7
| Subsidiary | Drugstore Chains | 7 |
| Public Company | Pharmaceuticals: Major | 6 | |
| Private Company | Financial Conglomerates | 6 | |
Nemucore Medical Innovations, Inc.
 Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA.
6
| Private Company | Pharmaceuticals: Major | 6 |
Artax Biopharma, Inc.
 Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA.
6
| Holding Company | Medical Specialties | 6 |
Clear Creek Bio, Inc.
 Clear Creek Bio, Inc. Pharmaceuticals: MajorHealth Technology Clear Creek Bio, Inc. engages in the development of therapies that target nucleotide synthesis pathways. The firm focuses on the differentiation blockade in cancer and suppress replication of RNA-based viruses. It uses pharmacodynamic markers to ensure that each patient gets the right drug at the correct dose. The company was founded by David T. Scadden, David B. Sykes, Burt A. Adelman, and Vikram Sheel Kumar in 2017 and is headquartered in Cambridge, MA.
6
| Private Company | Pharmaceuticals: Major | 6 |
| Public Company | Pharmaceuticals: Major | 6 | |
Arcturus Studios Holdings, Inc.
 Arcturus Studios Holdings, Inc. Packaged SoftwareTechnology Services Arcturus Studios Holdings, Inc. specializes in editing and compressing volumetric video through their holostream and holosuite products. Arcturus Studios Holdings is based in Beverly Hills, CA and has subsidiaries in Canada. These products provide adaptive streaming volumetric video for uninterrupted experiences delivered on demand. The company has received positive feedback from clients such as Crescent Studios, Far East Company, Inc., and NTT Docomo, Inc. for their professional-grade tools and ability to anticipate customer needs. Holoedit and holosuite have been used in various projects, including those featuring BTS and the 2019 Samsung Developer Conference. The company was founded by Devin Horsman, Andy Stack, and Ewan Johnson, and the CEO is Kamal Mistry.
6
| Holding Company | Packaged Software | 6 |
Myeloid Therapeutics, Inc.
 Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA.
5
| Holding Company | Biotechnology | 5 |
| Extinct | Financial Conglomerates | 5 | |
Antolrx, Inc.
 Antolrx, Inc. BiotechnologyHealth Technology Antolrx, Inc. operates in the healthcare industry focusing on biotechnology business. The company was founded by Mark Carthy and is headquartered in Boston, MA.
4
| Holding Company | Biotechnology | 4 |
Apic Bio, Inc.
 Apic Bio, Inc. Packaged SoftwareTechnology Services Apic Bio, Inc. engages in the development of treatment for neurological and liver diseases. It offers THRIVE, a platform that silences a mutant gene product and replaces a normal gene product in a single dual function vector. The company was founded by Robert H. Brown, Jr., John Reilly, and Christian Mueller in 2017 and is headquartered in North Cambridge, MA.
4
| Holding Company | Packaged Software | 4 |
SG DAN Holdings LLC
 SG DAN Holdings LLC Financial ConglomeratesFinance SG DAN Holdings LLC operates as an investment holding firm. The company is headquartered in New York, NY.
4
| Private Company | Financial Conglomerates | 4 |
Privo Technologies, Inc.
 Privo Technologies, Inc. Pharmaceuticals: MajorHealth Technology Privo Technologies, Inc. engages in biotechnology company. The firm focuses on oral cancer, intra-opertaive chemotherapy and HPV caused cancers. The company was founded by Manijeh Goldberg and is headquartered in Peabody, MA.
3
| Private Company | Pharmaceuticals: Major | 3 |
| Public Company | Pharmaceuticals: Major | 2 | |
United Neuroscience Ltd.
 United Neuroscience Ltd. BiotechnologyHealth Technology Part of Vaxxinity, Inc., United Neuroscience Ltd. is an Irish clinical stage biotech company. The private company is based in Dublin, Ireland.
1
| Subsidiary | Biotechnology | 1 |
Matrivax Research & Development Corp.
 Matrivax Research & Development Corp. BiotechnologyHealth Technology Matrivax Research & Development Corp. is developing human vaccines for the prevention and treatment of life-threatening bacterial diseases. Its pipeline includes two vaccine candidates implementing proprietary streptococcus pneumoniae and clostridium difficile protective antigens. The company was founded in October 2007 and is headquartered in Boston, MA.
1
| Holding Company | Biotechnology | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Daniel Geffken
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| VIVUS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Director of Finance/CFO Director/Board Member | |
| University of Virginia | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Director/Board Member Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| University of Toronto | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| University of California San Diego | College/University | Director/Board Member Doctorate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Doctorate Degree Undergraduate Degree | |
| University of Michigan | College/University | Corporate Officer/Principal Masters Business Admin | |
| The University of Sydney | College/University | Undergraduate Degree Doctorate Degree | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
San Diego Regional Economic Development Corp.
 San Diego Regional Economic Development Corp. Miscellaneous Commercial ServicesCommercial Services San Diego Regional Economic Development Corp. operates as a non-profit organization. It mobilizes business, government, and civic leaders to maximize the region’s economic prosperity and global competitiveness. The company is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| TALPHERA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
CONNECT
 CONNECT Miscellaneous Commercial ServicesCommercial Services CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
Caxton Health Holdings LLC
 Caxton Health Holdings LLC Financial ConglomeratesFinance Caxton Health Holdings LLC operates as an investment firm. It focus on healthcare sectors, such as healthcare technologies, biopharmaceuticals, drug discovery technology and healthcare information technology. The company is headquartered in New York, NY. | Financial Conglomerates | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Advent Life Sciences LLP
 Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The private company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Chairman Director of Finance/CFO | |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director of Finance/CFO Director/Board Member | |
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| VBI VACCINES INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
MatriSys Bioscience, Inc.
 MatriSys Bioscience, Inc. BiotechnologyHealth Technology MatriSys Bioscience, Inc. engages in the development of biologic therapeutics. It offers therapies for dermatology and skin care conditions including atopic dermatitis, rosacea, psoriasis, acne, and skin infections. The company was founded by Mark S. Wilson and Richard L. Gallo in 2015 and is headquartered in La Jolla, CA. | Biotechnology | Chairman Director/Board Member | |
| PARATEK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Founder | |
Valence Life Sciences LLC
 Valence Life Sciences LLC Investment ManagersFinance Valence Life Sciences LLC (Valence Life Sciences) is an venture capital firm founded in 2012 by Rachel Anne Leheny and Eric Wayne Roberts. The firm is headquartered in New York. | Investment Managers | Founder Founder | |
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Founder |
Statistik
International
| Vereinigte Staaten | 43 |
| Vereinigtes Königreich | 3 |
| Schweiz | 2 |
| Kanada | 2 |
| Australien | 2 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 16 |
| Finance | 7 |
| Commercial Services | 5 |
Operativ
| Director/Board Member | 654 |
| Corporate Officer/Principal | 241 |
| Independent Dir/Board Member | 163 |
| Founder | 111 |
| Chairman | 103 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Raj Bhikhu Parekh | 50 |
| Tomer Kariv | 46 |
| Franklin Berger | 41 |
| Steven Rubin | 37 |
| Louis Lange | 35 |
| Peter Farrell | 34 |
| Stephen J. Hoffman | 33 |
| Magda Marquet | 30 |
| Fred Middleton | 30 |
| David Epstein | 28 |
| Daniel Burgess | 27 |
| David Scadden | 26 |
| Howard Rosen | 26 |
| Andrew Sassine | 24 |
| Mark P. Carthy | 23 |
- Börse
- Insiders
- Daniel Geffken
- Unternehmensverbindungen
